Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/48156
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Vidal-Mosquera, Miquel | - |
dc.contributor.author | Fernández-Carvajal, Asia | - |
dc.contributor.author | Moure, Alejandra | - |
dc.contributor.author | Valente, Pierluigi | - |
dc.contributor.author | Planells-Cases, Rosa | - |
dc.contributor.author | González-Ros, José M. | - |
dc.contributor.author | Bujons, Jordi | - |
dc.contributor.author | Ferrer-Montiel, Antonio | - |
dc.contributor.author | Messeguer Peypoch, Ángel | - |
dc.date.accessioned | 2012-04-12T08:52:12Z | - |
dc.date.available | 2012-04-12T08:52:12Z | - |
dc.date.issued | 2011 | - |
dc.identifier.citation | Journal of Medicinal Chemistry | es_ES |
dc.identifier.issn | 0022-2623 | - |
dc.identifier.uri | http://hdl.handle.net/10261/48156 | - |
dc.description.abstract | The thermosensory transient receptor potential vanilloid 1 channel (TRPV1) is a polymodal receptor activated by physical and chemical stimuli. TRPV1 activity is drastically potentiated by proinflammatory agents released upon tissue damage. Given the pivotal role of TRPV1 in human pain, there is pressing need for improved TRPV1 antagonists, the development of which will require identification of new pharmacophore scaffolds. Uncompetitive antagonists acting as open-channel blockers might serve as activity-dependent blockers that preferentially modulate the activity of overactive channels, thus displaying fewer side effects than their competitive counterparts. Herein we report the design, synthesis, biological evaluation, and SAR analysis of a family of triazine-based compounds acting as TRPV1 uncompetitive antagonists. We identified the triazine 8aA as a potent, pure antagonist that inhibits TRPV1 channel activity with nanomolar efficacy and strong voltage dependency. It represents a new class of activity-dependent TRPV1 antagonists and may serve as the basis for lead optimization in the development of new analgesics. | es_ES |
dc.description.sponsorship | This work was supported by grants from Spanish Ministry of Science and Innovation (Grant SAF2008-00048 to A.M., Grant BFU2009-08346 to A.F.-M., CONSOLIDER-INGENIO 2010 (Grant CSD2008-00005) to A.F.-M., J.M.G.-R., and A.M.), from Fundació La Marató de TV3 (to A.F.-M. and A.M.), and from PROMETEO/2010/046 from the GVA to A.F.-M. | - |
dc.language.iso | eng | es_ES |
dc.publisher | American Chemical Society | es_ES |
dc.rights | closedAccess | es_ES |
dc.title | Triazine-Based Vanilloid 1 Receptor Open Channel Blockers: Design, Synthesis, Evaluation, and SAR Analysis | es_ES |
dc.type | artículo | es_ES |
dc.identifier.doi | 10.1021/jm200981s | - |
dc.description.peerreviewed | Peer reviewed | es_ES |
dc.relation.publisherversion | http://dx.doi.org/10.1021/jm200981s | es_ES |
dc.identifier.e-issn | 1520-4804 | - |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.openairetype | artículo | - |
item.cerifentitytype | Publications | - |
item.languageiso639-1 | en | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
Aparece en las colecciones: | (IQAC) Artículos |
CORE Recommender
SCOPUSTM
Citations
21
checked on 23-mar-2024
WEB OF SCIENCETM
Citations
19
checked on 27-feb-2024
Page view(s)
358
checked on 28-mar-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.